US20070151848A1 - Capacitance based biosensor - Google Patents
Capacitance based biosensor Download PDFInfo
- Publication number
- US20070151848A1 US20070151848A1 US11/614,580 US61458006A US2007151848A1 US 20070151848 A1 US20070151848 A1 US 20070151848A1 US 61458006 A US61458006 A US 61458006A US 2007151848 A1 US2007151848 A1 US 2007151848A1
- Authority
- US
- United States
- Prior art keywords
- sensor
- electrodes
- recited
- capacitance
- change
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
- G01N27/3275—Sensing specific biomolecules, e.g. nucleic acid strands, based on an electrode surface reaction
- G01N27/3276—Sensing specific biomolecules, e.g. nucleic acid strands, based on an electrode surface reaction being a hybridisation with immobilised receptors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
- Investigating Or Analyzing Materials By The Use Of Magnetic Means (AREA)
Abstract
Description
- This applications claims priority to U.S. provisional patent application Ser. No. 60/756,315.
- The present invention relates in general to biological sensors.
- Biological sensors are used in many areas of human life. The largest problem is one of portability and ease of use. One area of biosensor involves the interaction between an antibody and antigen; however, detection of the binding events when the antibody/antigen pair binds together is difficult due to a lack of electron transfer and the nature of the weak electrostatic forces involved. This drives a need for new transduction methods for the detection of these types of biological reactions.
- The term, “biomolecule-binding pairs,” means that specific binding will occur between a first member and a second member of a binding pair under defined conditions of ionic strength, temperature, pH and the like. The interaction may occur due to specific electrostatic, hydrophobic, or other interaction of certain residues of the first member with specific residues of the second member to form a stable complex under conditions effective to promote the interaction.
- Examples of biomolecule-binding pairs include, protein-protein interactions, protein-nucleic acid interactions, protein-small molecule interactions, nucleic acid-nucleic acid interactions, protein-fatty acid interactions, and protein-lipid interactions. A protein member of a binding pair may be an antigen, antibody, enzyme, hormone, receptor, regulatory protein, membrane protein, glycoprotein, proteoglycan, or a binding fragment, domain, or derivative of any of such proteins. A nucleic acid member of a binding pair may be deoxyribonucleic acid, or ribonucleic acid, binding fragment, domain or derivative of any of such nucleic acids. A member of a binding pair may also be a small molecule, or a substrate, for example.
- There are many biosensors that are based on optical techniques. These include surface plasmon resonance (SPR), laser induced fluorescence, and radiolabeling (Huang, et al, “Prostate-specific antigen immunosensing based on mixed self-assembled monolayers, camel antibodies and colloidal gold enhanced sandwich assays,” Biosensors and Bioelectronics 21 (2005) 483-490; Armbruster, D. A., 1993, Prostate-specific antigen; biochemistry, analytical methods, and clinical application, Clin. Chem. 39, 181-195; Cattini, R., Cooksey, M., Robinson, D., Brett, G., Bacarese-Hamilton, T., Jolley, N., 1993, Measurement of alpha-fetoprotein, carcinoembryonic antigen and prostate-specific antigen in serum and heparinised plasma by enzyme immunoassay on the fully automated sereno SR1 analyzer, Eur. J. Clin. Chem. Clin. Biochem. 31, 517-524; Thompson, M., Stone, D. C., 1997; Surface-Launched Acoustic Wave Sensors; Chemical Sensing and Thin-Film Characterization, John Wiley & Sons, New York; Stenberg, E., Persson, B., Roos, H., Urbaniczky, C., 1991, Quantitative determination of surface plasmon resonance using radiolabeled proteins, J. Colloid Interface Sci. 143, 513-526).
- SPR detects a change in reflected light caused by the bound biological pair on the surface. Usually, SPR is not portable due to sophisticated support electronics that are sensitive to placement and vibration. Fluorescence based methods require extensive modification of the target molecules that allow them to fluoresce light. These methods require that a fluorescent tag is able to be placed onto the target. This also requires intense laser-based excitation of the fluorophor to reach low detection limits. All of the optical techniques require large, complicated electronics to take the measurements. They can be made small enough to be called “bench top,” but not small enough to be handheld and portable.
-
FIG. 1A illustrates a sensor configured in accordance with an embodiment of the present invention; -
FIG. 1B illustrates a sensor array configured in accordance with an embodiment of the present invention; -
FIG. 1C illustrates an insulator layer on a sensor in accordance with an embodiment of the present invention; -
FIG. 2 illustrates a system configured in accordance with an embodiment of the present invention; -
FIG. 3 illustrates a graph of sensed biological substances; and -
FIG. 4 illustrates an exemplary output from the oscilloscope illustrating measurements of the output signal from the transformer coil. - Developed is an electrical method for testing biosensors. Electrical measurement of binding biological pairs is difficult. Many biosensors rely on an exchange of electrons during the reaction. This exchange of electrons (oxidation or reduction) of the analyte can be read as a change in resistance or current through the sensor. The problem with most biological reactions is the lack of electron transfer in the reaction. There are no electrons to be measured by conventional conductivity methods. Most biological pairs bond together via weak electrostatic forces. Examples of these pairs are DNA, RNA, and antibody/antigen pairs.
- To circumvent the problem of a lack of electron transfer in these antibody/antigen based biological systems, focus must be on the type of bonding. The electrostatic forces that hold these bio-pairs together are usually hydrogen-bonding and electrostatic interactions. Both of these have a characteristic shift in electron density near the bonding site without a transfer of electrons. This transfer of electron density can be thought of as a dielectric shift. The shift in dielectric potential can be measured as a change in capacitance. Advantage of this capacitance shift is taken to create an electrical measurement where it was once not possible. Prior art has shown other measurements of capacitance for bio sensing. Nearly all methods use impedence spectroscopy (Pei, et al., “Amplification of antigen-antibody interactions based on biotin labeled protein-streptavidin network complex using impedance spectroscopy,” Biosensors & Bioelectronics (2001) 355-361; Jina-Gou Guan, et al., “Impedimetric Biosensors,” Journal of Bioscience and Bioengineering, (2004) Vol. 97, No. 4, 219-226; O. Querghi, et al., “Impedimetric Immunosensor using avidin-biotin for antibody immobilization,” Bioelectrochemistry (2002) 56 131-133). Direct capacitance measurements have also been made (M. Riepl, et al. “Optimization of capacitive affinity sensors; drift suppression and signal amplification, ” Analytic Chimica Acta (1999) 392 77-84; V. Mirsky, “Capacitive monitoring of pritein immobilization and antigen-antibody reactions on monomolecular alkylthiol films on gold electrodes,” Biosensors & Bioelectronics (1997) 12 (9-10) 977-989). These previous methods utilize large electronic components. The electrometers, capacitance meters, lock-in amplifiers and analyzers are not portable and it would be impossible to put them into a handheld unit.
- Referring to
FIG. 1A , an embodiment of abiosensor 100 of the present invention utilizes two interdigitated electrodes. A receptor molecule (antibody or antigen) is attached to the electrodes. As an example, an antibody is attached to the surface with a covalent chemical tether. A “Covalent chemical tether” means a linker that is covalently bound to the sensor side of an electrode and to a first member of a biomolecule binding pair. The tether has a terminal functional group useful for such coupling, such as an amide, ester, disulfide, isocyanate or sulfhydryl group. In certain embodiments, the covalent bonding is via a carbon-nitrogen, carbon-sulfur, or a carbon-oxygen bond. - When the corresponding bio-molecule target analyte (antigen) binds to the antibody receptor, there is a change in capacitance between the two electrodes. The change in output signal is measured based on a change in impedance between the electrode pairs. This change in impedance is directly related to the change in capacitance and change in dielectric constant. Both the magnitude of the change (in mV) and the direction of change due to phase shift can be monitored, with each providing separate parts of the information describing the reaction. The work done by Mirsky et al. demonstrates a measurement using a lock-in amplifier to determine phase shift and a direct change in capacitance. The system of an embodiment of the present invention is an indirect measurement in capacitance that may be measured by a voltmeter. This important difference leads to a portable bio-sensing device.
- There are several contributions to the change in capacitance. These are all based on individual contributions to the change in dielectric. First, consider the shift in electron density at the bonding site. Due to the relative distribution of charge on each side of the reaction site, this is suspected to be quite small. For example, each antibody/antigen molecule has a large number of positively and negatively charged reaction sites. These usually are balanced and contribute to the overall neutral charge of the molecule. This balance of charge results in a small contribution. A second, significant contribution is based on a charge displacement of the double layer charge on the electrode.
- There is a small bias applied between the electrodes. When a drop of solution is placed atop the electrodes, a double-layer of alternating charge aligns at each electrode. The biomolecules have a large volume compared to the ions in the double layer. This size will displace the ions disturbing the double layer at the surface of the electrode. This change in double layer capacitance is measured.
- An embodiment of the present invention is based upon two pairs of electrodes. There are three electrodes 101-103 in each
sensor 100. Thecenter electrode 101 feeds an electrical signal to eachadjacent electrode outer electrodes sensor side 103 and areference side 102. Thereference side 102 is insulated from the fluid by an inert layer. This inert layer is inactive to the biological analyte. In this embodiment the layer is SiO2. In other embodiments the layer could be an electronically insulating organic or inorganic polymer. This inert layer prevents biological molecules from binding to its surface. Thesensor side 103 has a surface that is compatible with the binding of a biological layer. In one embodiment, the surface is gold and will accept a thiol-based tether to secure the antibody. As shown inFIG. 2 , the outputs of thesensor 103 andreference 102 electrodes are fed into abalanced transformer coil 202. This allows for amplification of the difference in output between thereference 102 andsensor 103 side. The inputs are balanced so the output from thecoil 202 is “zero” before the sensor activates. - In addition to detection of binding between binding pairs, the present biosensor is useful for identifying agonists or antagonists of such binding by observing a change in impedance measurements in the presence of the agonist or antagonist as compared to impedance measurements in the absence of such agents.
- An interdigitated array of gold electrodes 101-103 may be patterned onto a glass substrate using standard photolithography techniques. The gold electrodes allow for each surface modification by the analyte receptor. Each substrate may be comprised of two pairs of interdigitated electrodes sharing a common center feed. One pair will be considered a “sensor side” and one pair will be considered a “reference side”. The electrodes may be connected via feed lines that are non-parallel to reduce background capacitance. These feed lines may connect to trapezoidal shaped contact pads. Their shape may also be engineered to prevent background capacitance. As shown in
FIG. 1C , an insulatingoxide layer 104 prevents derivitization of thereference side 102 of the electrodes. The insulating oxide layer is configured so that it covers completely the reference side of the sensor electrodes. The insulating oxide layer has openings (vias) that allow derivatization of the sensor side of the electrodes. As shown inFIG. 1B , there may be six sets (or any number) of electrodes on each substrate.” - The substrate should not be conductive or have an underlying conductive layer. An underlying conductive layer (for example, a Si underlayer on a thermal SiO2 wafer) will have a larger capacitance with the surface electrodes than can be measured due to the bio-molecule reaction. This parasitic capacitance may swap out the measurable signal. An example of an insulating substrate would be polymer, plastic, glass, alumina or sapphire.
- The electrodes 101-103 may be patterned on the substrates using standard photolithography techniques. First, photo-resist (Shipley S1813, Rohm & Haas), may be deposited by spin-coating onto a clean glass substrate and then soft-baked in an oven at 90° C. for 45 minutes. The photo-resist layer may then be patterned by exposure to UV light (Cannon PLA-501F Mask Aligner) through an interdigitated electrode layer mask. The pattern may be developed using an aqueous solution of AZ 400K Developer (3:1% Vol, AZ Electronics Materials Corp.) The developed resist layer may be cleaned using a Reactive Ion Etch (Ar-ion etch, 102 Watts, 98 mtorr, Model RF5S, RF Power Products) prior to thin-film deposition. The gold electrodes may be deposited using an electron-beam evaporator (PlasmaTron P-30). 100 Å of chrome may be used as an adhesion layer followed by 500 Å of gold. The electrode pattern may then be developed by immersion in an acetone bath. Once lift-off is complete, the substrates may be rinsed with acetone followed by isopropanol, and finally dried under a N2 stream.
- The substrates may then be patterned using the same methods as above using the insulating layer maskset. After resist patterning and development, 750 Å of SiO2 may be deposited. This layer may be developed using the same lift-off procedure described above.
- As described, the interdigitated electrode pattern on the substrates may consist of three electrodes 101-103 which share the center electrode and comprise two pairs. Impedance between each pair of electrodes is measured. The direct capacitance of each electrode system is not measured, but rather looking at a change in impedance balance between the two pairs of electrodes. The change in impedance is directly related to the change in capacitance between the electrodes. There may be a measurable change in capacitance based on the binding of biological molecules between the electrodes.
- A schematic of the connections is shown in
FIG. 2 . AWavetek Function generator 201 may deliver a 500 kHz, 3Vpp sine wave input signal to thecenter electrode 101. The resulting output signal is delivered through each secondary electrode 102-103 for the sensor and reference sides, respectively. Thesensor side 103 has been derivatized as described above. Thereference side 102 may be coated with an insulating oxide as described above. The output from each electrode is then fed into abalanced transformer coil 202. When the capacitance and resulting impedance for each side of the electrode is equal, the resulting output from thecoil transformer 202 is zero. The coil output may be then sent to an oscilloscope 203 (Tektronix 2467 350 MHz), which allows measurement of the output voltage and any phase shift that may occur. - The capacitance of the dry electrodes may be balanced empirically by extending the length of the reference side of the electrodes. The length may be 1.5 times that of the sensor side. This difference may be an approximation based on the difference in dielectric constants of the insulating oxide layer and the electrode/biological/fluid layer present on the sensor side. This approximation results in a background signal that is 0.2% (7 mV output with 3V input) of the input when measured on the
oscilloscope 203. - Exemplary biological derivitizations were carried out. Multiple substrates were prepared. Each substrate had 6 sets of electrodes as shown in
FIG. 1B . Electrical measurements were taken after each step of the reaction. First, an amine-terminated thiol was attached to the gold surface. Second, biotin-NHS was attached to the amine group via an amide linkage. Streptavidin (SA) was then attached to the biotin. This SA was fluorescently labeled to verify binding. Successive bindings of anti-streptavidin were added. -
FIG. 3 shows output voltages from theoscilloscope 203 for each step of derivitization. It is clear that a large change in signal is present after each successive derivitization. This shows that there is a measurable change in capacitance due to the binding of each bio molecule. This simple change in voltage may be measured using a hand-held, portable device. It may also be designed into an integrated “package” with a plug-in bio-chip. - In addition to the change in output voltage, phase-shift may be monitored. This phase shift may be important for determining a difference between two molecules that show the same capacitance difference. The phase shift may be able to identify an increase or decrease in capacitance depending on direction. The phase shift may determine the difference between a reacted bio-molecule pair and a physisorbed non-reacted molecule. The phase shift may determine a change in dielectric constant, dipole moment and/or polarizability when combined with a magnitude of change.
-
FIG. 4 illustrates a diagram of how phase shift may enhance information gathered from the sensor. It shows the output signal from an oscilloscope. The vertical axis depicts the magnitude of the signal and the horizontal axis is the sine wave as a function of time. Three traces are offset and scaled for clarity. The upper trace is the input sine wave (3 Vpp) to the center electrode. The middle trace is the resulting output from the transformer. It has the same phase as the input signal but different (much smaller) magnitude at 300 mVpp. The lower trace is the resulting output after the sensor responds. The magnitude has changed to 400 mVpp and the phase has shifted by Φ1. The direction of the phase may tell us if there is an increase or decrease in capacitance relative to the initial input. For example, the same curve may be read as a phase shift, Φ2, in the opposite direction.
Claims (7)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/614,580 US7575720B2 (en) | 2006-01-05 | 2006-12-21 | Capacitance based biosensor |
PCT/US2006/062540 WO2008057122A2 (en) | 2006-01-05 | 2006-12-22 | Capacitance based biosensor |
TW096100050A TW200734640A (en) | 2006-01-05 | 2007-01-02 | Capacitance based biosensor |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75631506P | 2006-01-05 | 2006-01-05 | |
US11/614,580 US7575720B2 (en) | 2006-01-05 | 2006-12-21 | Capacitance based biosensor |
Publications (2)
Publication Number | Publication Date |
---|---|
US20070151848A1 true US20070151848A1 (en) | 2007-07-05 |
US7575720B2 US7575720B2 (en) | 2009-08-18 |
Family
ID=38223240
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/614,580 Expired - Fee Related US7575720B2 (en) | 2006-01-05 | 2006-12-21 | Capacitance based biosensor |
Country Status (3)
Country | Link |
---|---|
US (1) | US7575720B2 (en) |
TW (1) | TW200734640A (en) |
WO (1) | WO2008057122A2 (en) |
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100075340A1 (en) * | 2008-09-22 | 2010-03-25 | Mehdi Javanmard | Electrical Detection Of Biomarkers Using Bioactivated Microfluidic Channels |
WO2010118288A3 (en) * | 2009-04-10 | 2011-01-13 | Pharmaco-Kinesis Corporation | Method and apparatus for forming a homeostatic loop employing an aptamer biosensor |
WO2012060758A1 (en) * | 2010-11-01 | 2012-05-10 | Capsenze | A method of measuring a capacitance and a use |
US20130057304A1 (en) * | 2010-05-06 | 2013-03-07 | Seoul National University R&D Foundation | Capacitive element sensor and method for manufacturing same |
US8614056B2 (en) | 2010-03-24 | 2013-12-24 | The Board Of Trustees Of The Leland Stanford Junior University | Microfluidic method for measurement or detection involving cells or biomolecules |
WO2016043402A1 (en) * | 2014-09-19 | 2016-03-24 | 한국과학기술연구원 | Interdigitated microelectrode biosensor |
WO2016100325A1 (en) * | 2014-12-15 | 2016-06-23 | Virginia Tech Intellectual Properties, Inc. | Devices, systems, and methods for real-time monitoring of electrophysical effects during tissue treatment |
US10702326B2 (en) | 2011-07-15 | 2020-07-07 | Virginia Tech Intellectual Properties, Inc. | Device and method for electroporation based treatment of stenosis of a tubular body part |
US10828085B2 (en) | 2008-04-29 | 2020-11-10 | Virginia Tech Intellectual Properties, Inc. | Immunotherapeutic methods using irreversible electroporation |
US10959772B2 (en) | 2008-04-29 | 2021-03-30 | Virginia Tech Intellectual Properties, Inc. | Blood-brain barrier disruption using electrical energy |
US11254926B2 (en) | 2008-04-29 | 2022-02-22 | Virginia Tech Intellectual Properties, Inc. | Devices and methods for high frequency electroporation |
US11272979B2 (en) | 2008-04-29 | 2022-03-15 | Virginia Tech Intellectual Properties, Inc. | System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies |
US11311329B2 (en) | 2018-03-13 | 2022-04-26 | Virginia Tech Intellectual Properties, Inc. | Treatment planning for immunotherapy based treatments using non-thermal ablation techniques |
US11382681B2 (en) | 2009-04-09 | 2022-07-12 | Virginia Tech Intellectual Properties, Inc. | Device and methods for delivery of high frequency electrical pulses for non-thermal ablation |
US11406820B2 (en) | 2014-05-12 | 2022-08-09 | Virginia Tech Intellectual Properties, Inc. | Selective modulation of intracellular effects of cells using pulsed electric fields |
US11453873B2 (en) | 2008-04-29 | 2022-09-27 | Virginia Tech Intellectual Properties, Inc. | Methods for delivery of biphasic electrical pulses for non-thermal ablation |
US11607537B2 (en) | 2017-12-05 | 2023-03-21 | Virginia Tech Intellectual Properties, Inc. | Method for treating neurological disorders, including tumors, with electroporation |
US11607271B2 (en) | 2008-04-29 | 2023-03-21 | Virginia Tech Intellectual Properties, Inc. | System and method for estimating a treatment volume for administering electrical-energy based therapies |
US11638603B2 (en) | 2009-04-09 | 2023-05-02 | Virginia Tech Intellectual Properties, Inc. | Selective modulation of intracellular effects of cells using pulsed electric fields |
US11707629B2 (en) | 2009-05-28 | 2023-07-25 | Angiodynamics, Inc. | System and method for synchronizing energy delivery to the cardiac rhythm |
US11723710B2 (en) | 2016-11-17 | 2023-08-15 | Angiodynamics, Inc. | Techniques for irreversible electroporation using a single-pole tine-style internal device communicating with an external surface electrode |
US11779395B2 (en) | 2011-09-28 | 2023-10-10 | Angiodynamics, Inc. | Multiple treatment zone ablation probe |
US11890046B2 (en) | 2008-04-29 | 2024-02-06 | Virginia Tech Intellectual Properties, Inc. | System and method for ablating a tissue site by electroporation with real-time monitoring of treatment progress |
US11925405B2 (en) | 2018-03-13 | 2024-03-12 | Virginia Tech Intellectual Properties, Inc. | Treatment planning system for immunotherapy enhancement via non-thermal ablation |
US11931096B2 (en) | 2010-10-13 | 2024-03-19 | Angiodynamics, Inc. | System and method for electrically ablating tissue of a patient |
US11950835B2 (en) | 2019-06-28 | 2024-04-09 | Virginia Tech Intellectual Properties, Inc. | Cycled pulsing to mitigate thermal damage for multi-electrode irreversible electroporation therapy |
US11957405B2 (en) | 2013-06-13 | 2024-04-16 | Angiodynamics, Inc. | Methods of sterilization and treating infection using irreversible electroporation |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8958917B2 (en) | 1998-12-17 | 2015-02-17 | Hach Company | Method and system for remote monitoring of fluid quality and treatment |
US7454295B2 (en) | 1998-12-17 | 2008-11-18 | The Watereye Corporation | Anti-terrorism water quality monitoring system |
US9056783B2 (en) | 1998-12-17 | 2015-06-16 | Hach Company | System for monitoring discharges into a waste water collection system |
US8920619B2 (en) | 2003-03-19 | 2014-12-30 | Hach Company | Carbon nanotube sensor |
US8986523B2 (en) | 2012-01-19 | 2015-03-24 | International Business Machines Corporation | Biosensor capacitor |
WO2016109378A1 (en) * | 2014-12-29 | 2016-07-07 | North Carolina State University | Multiplexed diagnostic to recognize concentrations of related proteins and peptides |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6548311B1 (en) * | 1997-11-21 | 2003-04-15 | Meinhard Knoll | Device and method for detecting analytes |
US6718819B2 (en) * | 2001-09-10 | 2004-04-13 | Honeywell International Inc. | Oil quality sensor system, method and apparatus |
-
2006
- 2006-12-21 US US11/614,580 patent/US7575720B2/en not_active Expired - Fee Related
- 2006-12-22 WO PCT/US2006/062540 patent/WO2008057122A2/en active Application Filing
-
2007
- 2007-01-02 TW TW096100050A patent/TW200734640A/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6548311B1 (en) * | 1997-11-21 | 2003-04-15 | Meinhard Knoll | Device and method for detecting analytes |
US6718819B2 (en) * | 2001-09-10 | 2004-04-13 | Honeywell International Inc. | Oil quality sensor system, method and apparatus |
Cited By (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11655466B2 (en) | 2008-04-29 | 2023-05-23 | Virginia Tech Intellectual Properties, Inc. | Methods of reducing adverse effects of non-thermal ablation |
US10828086B2 (en) | 2008-04-29 | 2020-11-10 | Virginia Tech Intellectual Properties, Inc. | Immunotherapeutic methods using irreversible electroporation |
US11453873B2 (en) | 2008-04-29 | 2022-09-27 | Virginia Tech Intellectual Properties, Inc. | Methods for delivery of biphasic electrical pulses for non-thermal ablation |
US11890046B2 (en) | 2008-04-29 | 2024-02-06 | Virginia Tech Intellectual Properties, Inc. | System and method for ablating a tissue site by electroporation with real-time monitoring of treatment progress |
US11952568B2 (en) | 2008-04-29 | 2024-04-09 | Virginia Tech Intellectual Properties, Inc. | Device and methods for delivery of biphasic electrical pulses for non-thermal ablation |
US10959772B2 (en) | 2008-04-29 | 2021-03-30 | Virginia Tech Intellectual Properties, Inc. | Blood-brain barrier disruption using electrical energy |
US10828085B2 (en) | 2008-04-29 | 2020-11-10 | Virginia Tech Intellectual Properties, Inc. | Immunotherapeutic methods using irreversible electroporation |
US11272979B2 (en) | 2008-04-29 | 2022-03-15 | Virginia Tech Intellectual Properties, Inc. | System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies |
US11737810B2 (en) | 2008-04-29 | 2023-08-29 | Virginia Tech Intellectual Properties, Inc. | Immunotherapeutic methods using electroporation |
US11254926B2 (en) | 2008-04-29 | 2022-02-22 | Virginia Tech Intellectual Properties, Inc. | Devices and methods for high frequency electroporation |
US11607271B2 (en) | 2008-04-29 | 2023-03-21 | Virginia Tech Intellectual Properties, Inc. | System and method for estimating a treatment volume for administering electrical-energy based therapies |
US20100075340A1 (en) * | 2008-09-22 | 2010-03-25 | Mehdi Javanmard | Electrical Detection Of Biomarkers Using Bioactivated Microfluidic Channels |
US11638603B2 (en) | 2009-04-09 | 2023-05-02 | Virginia Tech Intellectual Properties, Inc. | Selective modulation of intracellular effects of cells using pulsed electric fields |
US11382681B2 (en) | 2009-04-09 | 2022-07-12 | Virginia Tech Intellectual Properties, Inc. | Device and methods for delivery of high frequency electrical pulses for non-thermal ablation |
WO2010118288A3 (en) * | 2009-04-10 | 2011-01-13 | Pharmaco-Kinesis Corporation | Method and apparatus for forming a homeostatic loop employing an aptamer biosensor |
CN102803944A (en) * | 2009-04-10 | 2012-11-28 | 药物代谢动力公司 | Method and apparatus for forming a homeostatic loop employing an aptamer biosensor |
US11707629B2 (en) | 2009-05-28 | 2023-07-25 | Angiodynamics, Inc. | System and method for synchronizing energy delivery to the cardiac rhythm |
US8614056B2 (en) | 2010-03-24 | 2013-12-24 | The Board Of Trustees Of The Leland Stanford Junior University | Microfluidic method for measurement or detection involving cells or biomolecules |
US9103773B2 (en) * | 2010-05-06 | 2015-08-11 | Seoul National University R&D Foundation | Capacitive element sensor and method for manufacturing same |
US20130057304A1 (en) * | 2010-05-06 | 2013-03-07 | Seoul National University R&D Foundation | Capacitive element sensor and method for manufacturing same |
US11931096B2 (en) | 2010-10-13 | 2024-03-19 | Angiodynamics, Inc. | System and method for electrically ablating tissue of a patient |
US9304096B2 (en) | 2010-11-01 | 2016-04-05 | Capsenze Hb | Method of measuring a capacitance |
KR101831365B1 (en) | 2010-11-01 | 2018-02-22 | 카프센제 에이치비 | Method of measuring a capacitance |
WO2012060758A1 (en) * | 2010-11-01 | 2012-05-10 | Capsenze | A method of measuring a capacitance and a use |
US10702326B2 (en) | 2011-07-15 | 2020-07-07 | Virginia Tech Intellectual Properties, Inc. | Device and method for electroporation based treatment of stenosis of a tubular body part |
US11779395B2 (en) | 2011-09-28 | 2023-10-10 | Angiodynamics, Inc. | Multiple treatment zone ablation probe |
US11957405B2 (en) | 2013-06-13 | 2024-04-16 | Angiodynamics, Inc. | Methods of sterilization and treating infection using irreversible electroporation |
US11406820B2 (en) | 2014-05-12 | 2022-08-09 | Virginia Tech Intellectual Properties, Inc. | Selective modulation of intracellular effects of cells using pulsed electric fields |
WO2016043402A1 (en) * | 2014-09-19 | 2016-03-24 | 한국과학기술연구원 | Interdigitated microelectrode biosensor |
US20170360326A1 (en) * | 2014-12-15 | 2017-12-21 | Virginia Tech Intellectual Properties, Inc. | Devices, systems, and methods for real-time monitoring of electrophysical effects during tissue treatment |
US11903690B2 (en) * | 2014-12-15 | 2024-02-20 | Virginia Tech Intellectual Properties, Inc. | Devices, systems, and methods for real-time monitoring of electrophysical effects during tissue treatment |
US20200260987A1 (en) * | 2014-12-15 | 2020-08-20 | Virginia Tech Intellectual Properties, Inc. | Devices, systems, and methods for real-time monitoring of electrophysical effects during tissue treatment |
US10694972B2 (en) * | 2014-12-15 | 2020-06-30 | Virginia Tech Intellectual Properties, Inc. | Devices, systems, and methods for real-time monitoring of electrophysical effects during tissue treatment |
WO2016100325A1 (en) * | 2014-12-15 | 2016-06-23 | Virginia Tech Intellectual Properties, Inc. | Devices, systems, and methods for real-time monitoring of electrophysical effects during tissue treatment |
US11723710B2 (en) | 2016-11-17 | 2023-08-15 | Angiodynamics, Inc. | Techniques for irreversible electroporation using a single-pole tine-style internal device communicating with an external surface electrode |
US11607537B2 (en) | 2017-12-05 | 2023-03-21 | Virginia Tech Intellectual Properties, Inc. | Method for treating neurological disorders, including tumors, with electroporation |
US11925405B2 (en) | 2018-03-13 | 2024-03-12 | Virginia Tech Intellectual Properties, Inc. | Treatment planning system for immunotherapy enhancement via non-thermal ablation |
US11311329B2 (en) | 2018-03-13 | 2022-04-26 | Virginia Tech Intellectual Properties, Inc. | Treatment planning for immunotherapy based treatments using non-thermal ablation techniques |
US11950835B2 (en) | 2019-06-28 | 2024-04-09 | Virginia Tech Intellectual Properties, Inc. | Cycled pulsing to mitigate thermal damage for multi-electrode irreversible electroporation therapy |
Also Published As
Publication number | Publication date |
---|---|
US7575720B2 (en) | 2009-08-18 |
WO2008057122A3 (en) | 2008-08-14 |
TW200734640A (en) | 2007-09-16 |
WO2008057122A2 (en) | 2008-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7575720B2 (en) | Capacitance based biosensor | |
EP1996734B1 (en) | Method and apparatus for target detection using electrode-bound viruses | |
Berggren et al. | Capacitive biosensors | |
Poghossian et al. | Label‐free sensing of biomolecules with field‐effect devices for clinical applications | |
Estrela et al. | Label-free sub-picomolar protein detection with field-effect transistors | |
US8072008B2 (en) | Biosensor having ultra fine fiber | |
US7732140B2 (en) | Method for direct electrical detection of molecules and molecule-molecule interactions | |
US8608919B2 (en) | Impedimetric sensor and applications thereof | |
US20020028441A1 (en) | Detection of molecules and molecule complexes | |
US20090117571A1 (en) | Impedance spectroscopy of biomolecules using functionalized nanoparticles | |
US20120037515A1 (en) | Impedimetric sensors using dielectric nanoparticles | |
US6503701B1 (en) | Analytic sensor apparatus and method | |
Xie et al. | A ten-minute, single step, label-free, sample-to-answer assay for qualitative detection of cytokines in serum at femtomolar levels | |
Bothara et al. | Nanomonitors: electrical immunoassays for protein biomarker profiling | |
KR101727107B1 (en) | Bio-sensor having microelectrode using dielectric substance electrophoresis | |
US20070072286A1 (en) | Label-free detection of biomolecules | |
Ahmed et al. | Immunosensors | |
JP2001510564A (en) | Microsystem for biological analysis and method for manufacturing the same | |
Hafaid et al. | Sensitivity improvement of an impedimetric immunosensor using functionalized iron oxide nanoparticles | |
US20130274131A1 (en) | Advanced Reverse-phase Magnetic Immunoassay | |
Yu et al. | An impedance biosensor array for label-free detection of multiple antigen-antibody reactions | |
JP2012211819A (en) | Biosensor | |
Lee et al. | Nanogap Biomolecular Junction | |
Hafaid et al. | Research Article Sensitivity Improvement of an Impedimetric Immunosensor Using Functionalized Iron Oxide Nanoparticles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: NANO-PROPRIETARY, INC., TEXAS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:NOVAK, JAMES;SOUNDARRAJAN, PRABHU;TIKHONSKI, ALEXEI;AND OTHERS;REEL/FRAME:019302/0176;SIGNING DATES FROM 20061219 TO 20061220 |
|
FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY Free format text: PAYER NUMBER DE-ASSIGNED (ORIGINAL EVENT CODE: RMPN); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
AS | Assignment |
Owner name: APPLIED NANOTECH HOLDINGS, INC., TEXAS Free format text: CHANGE OF NAME;ASSIGNOR:NANO-PROPRIETARY, INC.;REEL/FRAME:022873/0865 Effective date: 20080610 |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
REMI | Maintenance fee reminder mailed | ||
LAPS | Lapse for failure to pay maintenance fees |
Free format text: PATENT EXPIRED FOR FAILURE TO PAY MAINTENANCE FEES (ORIGINAL EVENT CODE: EXP.) |
|
STCH | Information on status: patent discontinuation |
Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362 |
|
FP | Lapsed due to failure to pay maintenance fee |
Effective date: 20170818 |